Nayzilam (midazolam nasal spray – UCB) — Cigna
Intermittent episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures)
Initial criteria
- Patient is currently receiving maintenance antiseizure medication(s)
- The medication is prescribed by or in consultation with a neurologist
Approval duration
1 year